Abstract
The adequacy of perioperative haemostasis with a high-purity, plasma-derived factor VIII product containing von Willebrand factor was retrospectively evaluated in 39 patients with type 1, 2 or 3 von Willebrand disease who underwent 61 major or minor surgical or invasive procedures. Overall, 93.5% of the responses to treatment were rated as excellent or good by the physician investigators. These ratings were confirmed by an independent panel of physician referees.
MeSH terms
-
Adult
-
Drug Combinations
-
Factor VIII / therapeutic use*
-
Female
-
Hemostasis, Surgical*
-
Hemostatics / therapeutic use*
-
Humans
-
Male
-
Middle Aged
-
Postoperative Hemorrhage / prevention & control*
-
Retrospective Studies
-
Treatment Outcome
-
von Willebrand Diseases / drug therapy*
-
von Willebrand Diseases / surgery*
-
von Willebrand Factor / therapeutic use*
Substances
-
Drug Combinations
-
Hemostatics
-
factor VIII, von Willebrand factor drug combination
-
von Willebrand Factor
-
Factor VIII